The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
Open accessAbstract
Psoriasis is one of the most common T cell–mediated autoimmune diseases in humans. Although a role for the innate immune system in driving the autoimmune T cell cascade has been proposed, its nature remains elusive. We show that plasmacytoid predendritic cells (PDCs), the natural interferon (IFN)-α–producing cells, infiltrate the skin of psoriatic patients and become activated to produce IFN-α early during disease formation. In a xenograft model of human psoriasis, we demonstrate that blocking IFN-α signaling or inhibiting the ability of PDCs to produce IFN-α prevented the T cell–dependent development of psoriasis. Furthermore, IFN-α reconstitution experiments demonstrated that PDC-derived IFN-α is essential to drive the development of psoriasis in vivo. These findings uncover a novel innate immune pathway for triggering a common human autoimmune disease and suggest that PDCs and PDC-derived IFN-α represent potential early targets for the treatment of psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Self-citationKadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964 · cited 2×
“This may reflect the specialization of PDCs to recognize distinct TLR ligands (39, 40), as well as their extraordinary ability to produce large amounts of IFN- , because of a prolonged endosomal retention of TLR ligands with consequent sustained MyD88/IRF-7 signaling (53).”
BackgroundSelf-citationInterferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
Self-citationSato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00053-4 · Cited by 1,339
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15
Zhang, X., Sun, S., Hwang, I., Tough, D. F., & Sprent, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80564-6 · Cited by 1,245
Grouard, G., Rissoan, M.-C., Filgueira, L., Durand, I., Banchereau, J., & Liu, Y.-J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1101 · Cited by 1,189
Self-citationTYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,042
Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J.-I., Uematsu, S., et al. (2004) · Nature Immunology · doi:10.1038/ni1118 · Cited by 1,033
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction
Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., & Taniguchi, T. (2005) · Nature · doi:10.1038/nature03547 · Cited by 912
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity
Kadowaki, N., Antonenko, S., Lau, J. Y.-N., & Liu, Y.-J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.219 · Cited by 849
Self-citationCross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 818
Immune surveillance in the skin: mechanisms and clinical consequences
Kupper, T. S., & Fuhlbrigge, R. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1310 · Cited by 805
Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., & Lanzavecchia, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3388::aid-immu3388>3.0.co;2-q · Cited by 788
Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Günther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1823 · Cited by 766
Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., & Jahnsen, F. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61689-6 · Cited by 730
Lebwohl, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12954-6 · Cited by 548
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
Nickoloff, B. J., & Nestle, F. O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422147 · Cited by 544 · cited 1×
“Although it is still unclear how these environmental factors drive the pathogenic T cell cascade, it has been suggested that innate immune pathways may provide the missing link (6, 7).”
BackgroundSelf-citationBoyman, O., Hefti, H. P., Conrad, C., Nickoloff, B. J., Suter, M., & Nestle, F. O. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031482 · Cited by 522
Self-citationBengtsson, A. A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., & Rönnblom, L. (2000) · Lupus · doi:10.1191/096120300674499064 · Cited by 464
Wollenberg, A., Günther, S., Moderer, M., Wetzel, S., Wagner, M., Towarowski, A., Tuma, E., Rothenfusser, S., Endres, S., & Hartmann, G. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19515.x · Cited by 461
Gilliet, M., Conrad, C., Geiges, M., Cozzio, A., Thürlimann, W., Burg, G., Nestle, F. O., & Dummer, R. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.12.1490 · Cited by 408
Self-citationToll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease
Lang, K. S., Recher, M., Junt, T., Navarini, A. A., Harris, N. L., Freigang, S., Odermatt, B., Conrad, C., Ittner, L. M., Bauer, S., et al. (2005) · Nature Medicine · doi:10.1038/nm1176 · Cited by 378
Self-citationFonteneau, J.-F., Gilliet, M., Larsson, M., Dasilva, I., Münz, C., Liu, Y.-J., & Bhardwaj, N. (2003) · Blood · doi:10.1182/blood-2002-10-3063 · Cited by 346
Self-citationIL-27 and IFN- α Signal via Stat1 and Stat3 and Induce T-Bet and IL-12R β 2 in Naive T Cells
Hibbert, L., Pflanz, S., de Waal Malefyt, R., & Kastelein, R. A. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900360708632 · Cited by 318
Nestle, F. O., Turka, L. A., & Nickoloff, B. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117308 · Cited by 306
Self-citationAutoimmunity through Cytokine-Induced Dendritic Cell Activation
Banchereau, J., Pascual, V., & Palucka, A. K. (2004) · Immunity · doi:10.1016/s1074-7613(04)00108-6 · Cited by 293
Induction of Type I Diabetes by Interferon-α in Transgenic Mice
Stewart, T. A., Hultgren, B., Huang, X., Pitts-Meek, S., Hully, J., & MacLachlan, N. J. (1993) · Science · doi:10.1126/science.8100367 · Cited by 285
Vallin, H., Perers, A., ALM, G. V., & Rönnblom, L. (1999) · PubMed · Cited by 284
Lew, W., Bowcock, A. M., & Krueger, J. G. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.006 · Cited by 284
Jahnsen, F. L., Lund-Johansen, F., Dunne, J. F., Farkas, L., Haye, R., & Brandtzaeg, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4062 · Cited by 271
Vallin, H., Perers, A., Alm, G. V., & Rönnblom, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6306 · Cited by 256
Interferon Expression in the Pancreases of Patients With Type I Diabetes
Huang, X., Yuang, J., Goddard, A., Foulis, A., James, R. F. L., Lernmark, Å., Pujol-Borrell, R., Rabinovitch, A., Somoza, N., & Stewart, T. A. (1995) · Diabetes · doi:10.2337/diab.44.6.658 · Cited by 255
Hida, S., Ogasawara, K., Sato, K., Abe, M., Takayanagi, H., Yokochi, T., Sato, T., Hirose, S., Shirai, T., Taki, S., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00064-9 · Cited by 251
Vanbervliet, B., Bendriss-Vermare, N., Massacrier, C., Homey, B., de Bouteiller, O., Brière, F., Trinchieri, G., & Caux, C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020437 · Cited by 248
Self-citationCederblad, B., Blomberg, S., Vallin, H., Perers, A., Alm, G. V., & Rönnblom, L. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1998.0215 · Cited by 215
Biology of tumor necrosis factor‐α– implications for psoriasis
Schottelius, A. J. G., Moldawer, L. L., Dinarello, C. A., Asadullah, K., Sterry, W., & Edwards, C. K. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00205.x · Cited by 195
Biological therapies in the systemic management of psoriasis: International Consensus Conference
Sterry, W., Barker, J., Boehncke, W.-H., Bos, J. D., Chimenti, S., Christophers, E., De La Brassinne, M., Ferrandiz, C., Griffiths, C., Katsambas, A., et al. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06070.x · Cited by 194
Induction of Clinical Autoimmune Disease by Therapeutic Interferon-α
Gota, C., & Calabrese, L. (2003) · Autoimmunity · doi:10.1080/08916930310001605873 · Cited by 176
Control of IFN-inducible MxA gene expression in human cells
Ronni, T., Melén, K., Malygin, A., & Julkunen, I. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.1715 · Cited by 169
Lande, R., Giacomini, E., Serafini, B., Rosicarelli, B., Sebastiani, G. D., Minisola, G., Tarantino, U., Riccieri, V., Valesini, G., & Coccia, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2815 · Cited by 158
van der Fits, L., van der Wel, L. I., Laman, J. D., Prens, E. P., & Verschuren, M. C. M. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.22113.x · Cited by 132
Roers, A., Hochkeppel, H. K., Horisberger, M. A., Hovanessian, A. G., & Haller, O. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.4.807 · Cited by 126
Suomela, S., Cao, L. H., Bowcock, A. M., & Saarialho‐Kere, U. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22322.x · Cited by 110
Vissers, W. H. P. M., Arndtz, C. H. M., Muys, L., van Erp, P. E. J., de Jong, E. M. G. J., & van de Kerkhof, P. C. M. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05863.x · Cited by 107
Psoriasis, T Cells and Autoimmunity
Griffiths, C. E. M., & Voorhees, J. J. (1996) · Journal of the Royal Society of Medicine · doi:10.1177/014107689608900604 · Cited by 67
Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C
Downs, A. M., & Dunnill, M. G. S. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00655-4.x · Cited by 59
Current concepts in the immunopathogenesis of psoriasis
Lowes, M. A., Lew, W., & Krueger, J. G. (2004) · Dermatologic Clinics · doi:10.1016/j.det.2004.03.010 · Cited by 52
Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid
Krinks, C. H. V. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh115 · Cited by 47
Cited by
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Self-citationBoehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E., & Barker, J. N. W. N. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32549-6 · Cited by 2,383
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176
Metadata
- Authors
- Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.-J., & Gilliet, M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-07-04
- Volume
- 202
- Issue
- 1
- Pages
- 135-143
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2169758620
- Cited by
- 1,124
- References
- 56
- FWCI
- 18.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.